Tolga Tanguler - 05 Jul 2022 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
EVP, Chief Commercial Officer
Signature
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Tolga Tanguler
Issuer symbol
ALNY
Transactions as of
05 Jul 2022
Net transactions value
-$263,100
Form type
4
Filing time
07 Jul 2022, 16:06:11 UTC
Previous filing
25 Feb 2022
Next filing
05 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Sale $263,100 -1,754 -50% $150.00 1,754 05 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2022.